$IMAX

GELFOND RICHARD L sold $24.0M of IMAX

GELFOND RICHARD L (Chief Executive Officer) sold 456,757 shares of IMAX CORP (IMAX) at an average of $52.51 ($51.00–$53.27, $23.98M total) across 3 trades over 2026-08-18 to 2026-08-20 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · GELFOND RICHARD L
Published Aug 20, 2026, 9:37 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 20, 2026, 9:43 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$IMAX
Bearish
medium confidence
Mentioned
$IMAX
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$IMAXBearishMed
01

Why it matters

The disclosed sale reduces insider ownership and may trigger short‑term selling pressure, especially if the market perceives it as a lack of confidence.

02

Market read

Primary insider sale of material size; short‑term price impact likely.

03

What to watch

Potential upcoming corporate actions or financing needs not disclosed could justify the sale.

Relevance 6/10Novelty 8/10Timing: after-market 2026-08-20

Background

Form 4 filings provide the first public disclosure of insider transactions. Richard Gelfond's 10b5‑1 plan sale is a standard mechanism for executives to liquidate shares.

Company-level read

Ticker impact

$IMAXBearishMedium confidence
Context

CEO Richard Gelfond sold ~24M USD of IMAX shares via a 10b5-1 plan, reducing his stake to 665,002 shares.

Expected impact

Downward pressure of 2-4% over the next few days.

Evidence & confidence

The sale size (~$24M) is material for a mid‑cap company and was disclosed via a Form 4, a primary source. No accompanying corporate news offsets the negative signal.

Market effects

May weigh on other cinema and entertainment stocks as investors reassess insider confidence.

Limited to US equities; no broader regional effect.

Low; impact confined to IMAX and related peers.

Counterpoint

The sale could be a routine liquidity event under a pre‑arranged plan, not a bearish signal.

Key entities

  • Richard Gelfond

    CEO of IMAX Corp, insider selling 456,757 shares.

  • IMAX Corp

    US‑listed cinema technology company (ticker IMAX).

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$IMAXMed

IMAX at Bank of America 2026 Media,Communications & Entertainment Conference: global surge

IMAX Corporation (IMAX) reported strong global growth at the Bank of America 2026 Media, Communications & Entertainment Conference. CEO Rich Gelfond highlighted record box office performance, international expansion, and new revenue streams. Current-quarter box office is on track to exceed $600 million, with significant contributions from international markets and local-language films. The company operates 1,800 theaters, with 500 in backlog, and aims to expand further. IMAX is also diversifying

$IMAXMed

Why IMAX Stock Climbed to a New All-Time High Today

IMAX stock reached a new all-time high on Monday, rising 3.89% to $54.79. The surge was driven by the record-breaking success of The Odyssey, which became the highest-grossing IMAX release. CEO Rich Gelfond expects this to be their best year. Analyst Steve Frankel predicts IMAX will exceed estimates in the second half of 2026, with shares potentially rising to $60. The company's Q2 2026 revenue grew 12% to $103 million, with adjusted earnings up 65% to $0.43 per share.

$IMAXMed

“The Odyssey” Demand Drives IMAX Shares Higher

IMAX reported Q2 2026 revenue of $103M (up 12% YoY) and EPS of $0.43 (up 65%), driven by strong demand for 'The Odyssey'. The stock has gained 42% YTD, with institutional inflows contributing to a 103.5% rise over the past year. IMAX shows strong sales and EPS growth rates of 11.7% and 18.7% respectively over three years, with EPS expected to rise 14% this year.

$IMAXMed

Why IMAX Stock Rallied on Monday

IMAX shares rose about 5% on Monday after the company said Christopher Nolan’s film The Odyssey became the highest-grossing IMAX release of all time. IMAX reported $289 million in ticket sales, plus $37 million in the fourth weekend, and said IMAX theaters account for 26% of total tickets. IMAX added that 70mm locations have grossed over $37 million and presales near $40 million.

$IMAXMed

Why IMAX Stock Soared on Monday

IMAX said The Odyssey helped it post its highest-ever monthly box-office results, with July box-office revenue of $257 million, up 47% from the prior record. Ticket sales for The Odyssey totaled $221 million. IMAX also announced an upcoming run for Spider-Man: Brand New Day and shares closed Monday nearly 7% higher.